Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Head & Neck 2Breast 2Gastrointestinal 1

Conditions

Neuroma, Acoustic 3

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Gentamicins × CNS × Clear all
NCT02379754 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

NCT02415257 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

NCT02963896 2016-11-15

ITG

University Hospital, Motol

Phase NA Completed
20 enrolled
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡